Скачать или смотреть Tony’s Takeaway: Make or break biotechs and Phase 3 trials

This week, Tony Locantro turns his attention to the boom or bust nature of pivotal phase 3 trials, looking at one to watch in Dimerix (ASX:DXB) and what mix of biotechs to include in your portfolio.

Watch the video to hear more.

The views, information or opinions expressed in this video are those solely of the contributor, and not those of Stockhead. Stockhead does not provide, endorse or otherwise assume any responsibility for any financial advice contained in this video.

While Dimerix is a Stockhead advertiser, it did not sponsor this content.

The contributor may have a financial interest in some or all of the companies mentioned.
_____
For more free daily ASX news, visit:
🔗 https://stockhead.com.au

Subscribe to the free newsletter:
📰 https://stockhead.com.au/subscribe

Follow:
LinkedIn:   / stockhead  
Facebook:   / stockheadau  
X:   / stockheadau  
Apple News: 🍎 https://apple.news/T1RAxifC9TtOJHZYNL...
Threads: 🧵 https://threads.net/@stockheadau
______

#ASX #stockhead #investing #stockmarket #news #markettrends #asxnews #usa #tarrifs #clinicaltrials #phase3 #biotech #biotechstocks